Medical Marketing & Media

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Professional Media Group. (Media Assignments).
May 01, 2003

The National Football. (Update).
May 01, 2003

GSK brings Advair to the racing crowd. (DTC Report).
May 01, 2003

Pfizer turns to Edelman. (Public Relations).
May 01, 2003

A marketer's cure for attention deficit disorder.
May 01, 2003

[0] The FDA. (Update).
May 01, 2003

Grey gets Wyeth's low-dose Prempro. (News).
May 01, 2003

DTC speakers focus on market's future. (News).
May 01, 2003

Together Rx unveils highly anticipated ad campaign. (News).
May 01, 2003

The FDA. (Update).
May 01, 2003

Novartis. (Update).
May 01, 2003

Court approves 'prior authorization'. (News).
May 01, 2003

PhRMA forges ahead without PR chief. (News).
May 01, 2003

A new treatment. (Pipeline).
May 01, 2003

Pharmacia. (Pipeline).
May 01, 2003

The surprising world of public policy: a closer look at ALLHAT and Sar...
May 01, 2003

Insurers push up prices of allergy drugs. (News).
May 01, 2003

Drug companies grapple with HIPAA, avoid use of patient privacy statem...
May 01, 2003

FCB's Domanico, Maiman add CEO to their job titles. (News).
May 01, 2003

As I see it. (Washington Insider).
May 01, 2003

FDA defends label control. (Washington Insider).
May 01, 2003

Free speech watchdog challenges ACCME's proposed med-ed standards. (Wa...
May 01, 2003

Ninety illegal pharmacy. (Update).
May 01, 2003

AMP gets lowdown on touting journals. (Media).
May 01, 2003

Does size matter for journal ads? (Media Forum).
May 01, 2003

Web watch. (E-Marketing).
May 01, 2003

AstraZeneca finds comfort in consolidation. (In Focus).
May 01, 2003

PR view. (Public Relations).
May 01, 2003

6 up 2 down.
May 01, 2003

Wall street choice: Merck, a renaissance in the making.
May 01, 2003

The art of branding a condition.
May 01, 2003

IMS review: steady but not stellar.
May 01, 2003